Advertisement
Research Article| Volume 12, ISSUE 4, P743-757, December 1992

Special Issues in Transfusion Medicine

  • Chantal R. Harrison
    Correspondence
    Address reprint requests to: Chantal R. Harrison, MD, Department of Pathology, The University of Texas, Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284-7750
    Affiliations
    From the Department of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

    The Department of Blood Bank, Medical Center Hospital, San Antonio, Texas
    Search for articles by this author
  • Phyllis R. Sawyer
    Affiliations
    Department of Pathology, Blood Bank, Concord Hospital, Concord, New Hampshire
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30485-2
Special Issues in Transfusion Medicine
Previous ArticleImmunosuppressive Effects of Blood Transfusion
Next ArticleNew Testing Approaches in Transfusion Medicine
      This paper is only available as a PDF. To read, Please Download here.
      This article reviews four controversial aspects of transfusion practices: the clinical circumstances, survival, and complications of massive transfusion; specific problems related to neonatal transfusion practices and the surgical support of the small child, including the appropriate age for red cells to be transfused, cytomegalovirus transmission, and the reduction in homologous donor exposures; the clinical presentation, incidence, and prevention of transfusion-associated graft-versus-host disease; and the biochemistry, function, genetics, and clinical indication for replacement therapy of anti thrombin III.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Adler S.P.
        • Chandrika T.
        • Lawrence L.
        • et al.
        Cytomegalovirus infections in neonates acquired by blood transfusions.
        Pediatr Infect Dis. 1983; 2: 114
        • Anderson K.C.
        • Goodnough L.T.
        • Sayers M.
        • et al.
        Variation in blood component irradiation practice: Implication for prevention of transfusion-associated graft-versus- host disease.
        Blood. 1991; 77: 2096
        • Anderson K.C.
        • Weinstein H.J.
        Transfusion-associated graft-versus-host disease.
        N Engl J Med. 1990; 323: 315
        • Andreau G.
        • Boccaccio C.
        • Lecrubier C.
        • et al.
        Ultraviolet irradiation of platelet concentrates: Feasibility in transfusion practice.
        Transfusion. 1990; 30: 401
        • Arsura E.L.
        • Bertelle A.
        • Minkowitz S.
        • et al.
        Transfusion-associated graft-versus-host disease in a presumed immunocompetent patient.
        Arch Intern Med. 1988; 148: 1941
        • Becker R.C.
        • Corrao J.M.
        • Bovill E.G.
        • et al.
        Intravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality.
        Am Heart J. 1990; 119: 1254
        • Berger R.S.
        • Dixon S.L.
        Fulminant transfusion-associated graft-versus-host disease in a premature infant.
        J Am Acad Dermatol. 1989; 20: 945
        • Blasko G.
        The biochemistry of antithrombin III.
        in: Sas G. The Biology of Antithrombins. CRC Press, Boca Raton, FL1990
        • Blauhut B.
        • Kramar H.
        • Vinazzer H.
        • et al.
        Substitution of antithrombin III in shock and DIC: A randomized study.
        Thromb Res. 1985; 39: 81
        • Bowden R.A.
        • Sayers M.H.
        • Cays M.
        • et al.
        The role of blood product filtration in the prevention of transfusion associated cytomegalovirus (CMV) infection after marrow transplant [abstract].
        Transfusion. 1989; 29: 57S
        • Bowden R.A.
        • Slichter S.J.
        • Sayers M.H.
        • et al.
        Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
        Blood. 1991; 78: 246
        • Brecher M.E.
        • Moore S.B.
        • Taswell H.F.
        Minimal-exposure transfusion: A new approach to homologous blood transfusion.
        Mayo Clin Proc. 1988; 63: 903
        • Brown M.S.
        • Garcia J.F.
        • Phibbs R.H.
        • et al.
        Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity.
        J Pediatr. 1984; 105: 793
        • Brown M.S.
        • Phibbs R.H.
        • Garcia J.F.
        • et al.
        Postnatal changes in erythropoietin levels in untransfused premature infants.
        J Pediatr. 1983; 103: 612
        • Brubaker D.B.
        Human posttransfusion graft-versus-host disease.
        Vox Sang. 1983; 45: 401
        • Button L.N.
        • DeWolf W.C.
        • Newburger P.E.
        • et al.
        The effect of irradiation on blood components.
        Transfusion. 1981; 21: 419
        • Capon S.M.
        • DePond W.D.
        • Tyan D.B.
        • et al.
        Transfusion-associated graft-versus-host disease in an immunocompetent patient.
        Ann Intern Med. 1991; 114: 1025
        • Courcy P.A.
        • Brotman S.
        • Dawson B.
        Massive blood transfusion in acute trauma [letter].
        Transfusion. 1983; 23: 404
        • DeCoste S.D.
        • Boudreaux C.
        • Dover J.S.
        Transfusion-associated graft-vs-host disease in patients with malignancies.
        Arch Dermatol. 1990; 126: 1324
        • Deeg H.J.
        • Graham T.C.
        • Gerhard-Miller L.
        • et al.
        Prevention of transfusion-induced graft-versus-host disease in dogs by ultraviolet irradiation.
        Blood. 1989; 74: 2592
        • Driscoll D.F.
        • Bistrian B.R.
        • Jenkins R.L.
        • et al.
        Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation.
        Crit Care Med. 1987; 15: 905
        • Egeberg O.
        Inherited antithrombin deficiency causing thrombophilia.
        Thromb Diath Haemorrh. 1965; 13: 516
        • Einarsson M.
        • Perenius L.
        • McDougal J.S.
        • et al.
        Heat inactivation of human immunodeficiency virus in solutions of antithrombin III.
        Transfusion. 1989; 29: 148
        • Farmer M.
        • Ebeling A.
        • Marshall T.
        • et al.
        Virus inactivation in diaspirin crosslinked hemoglobin solution by heat treatment [abstract].
        Transfusion. 1991; 31: 42S
      25. FDA approves human safety testing of blood substitute.
        Blood Bank Week. 1991; 8: 3
        • Ferrara A.
        • MacArthur J.D.
        • Wright H.K.
        • et al.
        Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion.
        Am J Surg. 1990; 160: 515
        • Flancbaum L.
        • Trooskin S.Z.
        • Pedersen H.
        Evaluation of blood-warming devices with the apparent thermal clearance.
        Ann Emerg Med. 1989; 18: 355
        • Funkhouser A.W.
        • Vogelsang G.
        • Zehnbauer B.
        • et al.
        Graft versus host disease after blood transfusion in a premature infant.
        Pediatrics. 1991; 87: 247
        • Gallus A.S.
        Replacement therapy in antithrombin III deficiency.
        Transfusion Med Rev. 1989; 3: 253
        • Gilbert G.L.
        • Hayes K.
        • Hudson I.L.
        • et al.
        Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes.
        Lancet. 1989; 1: 1228
        • de Graan-Hentzen Y.C.E.
        • Gratama J.W.
        • Mudde G.C.
        • et al.
        Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products.
        Transfusion. 1989; 29: 757
        • Halperin D.S.
        • Wacker P.
        • Lacourt G.
        • et al.
        Effect of recombinant erythropoietin in infants with the anemia of prematurity: A pilot study.
        J Pediatr. 1990; 116: 779
        • Harrigan C.
        • Lucas C.E.
        • Ledgerwood A.M.
        • et al.
        Serial changes in primary hemostasis after massive transfusion.
        Surgery. 1985; 98: 836
        • Hathaway W.E.
        • Githens J.H.
        • Blackburn W.R.
        • et al.
        Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children.
        N Engl J Med. 1965; 273: 953
        • Heaton A.
        • Keegan T.
        • Holme S.
        In vivo regeneration of red cell 2,3-diphosphogly- cerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells.
        Br J Haematol. 1989; 71: 131
        • Hellgren M.
        • Javelin L.
        • Hagnevik K.
        • et al.
        Antithrombin III concentrate as adjuvant in DIC treatment: A pilot study in nine severely ill patients.
        Thromb Res. 1984; 35: 459
        • Hewitt P.E.
        • Machin S.J.
        Massive blood transfusion.
        BMJ. 1990; 300: 107
        • Holland P.V.
        Prevention of transfusion-associated graft-vs-host disease.
        Arch Pathol Lab Med. 1989; 113: 285
        • Hong F.
        • Shastri K.A.
        • Logue G.L.
        • et al.
        Complement activation by artificial blood substitute Fluosol: In vitro and in vivo studies.
        Transfusion. 1991; 31: 642
        • Hume H.
        The transfusion support of pediatric patients with acquired or congenital bone marrow hypoplasia.
        in: Wilson S.M. Levitt J.S. Strauss R.G. Improving Transfusion Practice for Pediatric Patients. American Association of Blood Banks, Arlington, VA1991: 19
        • Isbister J.P.
        Haemotherapy for acute haemorrhage.
        Anaesth Intensive Care. 1984; 12: 217
        • Iserson K.V.
        • Huestis D.W.
        Blood warming: Current applications and techniques.
        Transfusion. 1991; 31: 558
        • Ito K.
        • Fujita M.
        • Norioka M.
        • et al.
        Postoperative erythroderma with change of HLA phenotypes from heterozygotes to homozygotes: A report of two cases.
        Eur J Haematol. 1991; 46: 217
        • Juji T.
        • Shibaka Y.
        • Takahashi K.
        • et al.
        Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan [letter].
        N Engl J Med. 1989; 321: 56
        • Kanter M.H.
        Risk of graft-versus-host disease (GVHD) as a result of directed donation from relatives [abstract].
        Transfusion. 1991; 31: 17S
        • Kessinger A.
        • Armitage J.O.
        • Klassen L.W.
        • et al.
        Graft versus host disease following transfusion of normal blood products to patients with malignancies.
        J Surg Oncol. 1987; 36: 206
        • Kivioja A.
        • Myllynen P.
        • Rokkanen P.
        Survival after massive transfusions exceeding four blood volumes in patients with blunt injuries.
        Am Surg. 1991; 57: 398
        • Knight P.
        Transgenic pigs produce human hemoglobin.
        ASM News. 1991; 57: 505
        • Kruskall M.S.
        • Alper C.A.
        • Awdeh Z.
        • et al.
        HLA-homozygous donors and transfusion- associated graft-versus-host disease [letter].
        N Engl J Med. 1990; 322: 1005
        • Lefebre J.
        • McLellan B.A.
        • Coovadia A.S.
        • et al.
        Seven years experience with group O unmatched packed red blood cells in a regional trauma center.
        Ann Emerg Med. 1987; 16: 1344
        • Leitman S.F.
        • Holland P.V.
        Irradiation of blood products.
        Transfusion. 1985; 25: 293
        • Leslie S.D.
        • Toy P.T.C.Y.
        Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid.
        Am J Clin Pathol. 1991; 96: 770
        • Lowenthal R.M.
        • Grossman L.
        • Goldman J.M.
        • et al.
        Granulocyte transfusions in treatment of infections in patients with acute leukemia and aplastic anemia.
        Lancet. 1975; 1: 353
        • Luban N.L.C.
        • Williams A.E.
        • McDonald M.
        • et al.
        Low incidence of cytomegalovirus infection in neonates transfused with washed red blood cells.
        Am J Dis Child. 1987; 141: 416
        • Luna G.K.
        • Maier R.V.
        • Pavlin E.G.
        • et al.
        Incidence and effect of hypothermia in seriously injured patients.
        J Trauma. 1987; 27: 104
        • Maki M.
        • Terao T.
        • Ikenoue T.
        • et al.
        Clinical evaluation of antithrombin III concentrate (BI6.013) for disseminated intravascular coagulation in obstetrics.
        Gynecol Obstet Invest. 1987; 23: 230
        • Manno C.S.
        • Hedberg K.W.
        • Kim H.C.
        • et al.
        Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children.
        Blood. 1991; 77: 930
        • Martin B.
        • Robin H.
        • William R.
        • et al.
        Neonatal graft versus host disease following transfusion of maternal platelets [abstract].
        Transfusion. 1983; 23: 417
        • Menache D.
        • O’Malley J.P.
        • Schorr J.B.
        • et al.
        Evaluation of the safety, recovery, halflife, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency.
        Blood. 1990; 75: 33
        • Michelsen T.
        • Salmela L.
        • Tigerstedt I.
        • et al.
        Massive blood transfusion: Is there a limit?.
        Crit Care Med. 1989; 17: 699
        • Monkhouse F.C.
        • France E.S.
        • Seegers W.H.
        Studies on the antithrombin and heparin cofactor activities of a fraction absorbed from plasma by aluminum hydroxide.
        Cir Res. 1955; 3: 397
        • Morawitz P.
        Die Chemie der Blutgerinnung.
        Ergeb Physiol. 1905; 4: 307
        • Mukherji B.
        • Sloviter H.A.
        A stable perfluorochemical blood substitute.
        Transfusion. 1991; 31: 324
        • Nelson C.C.
        • Otteson S.P.
        • Johnson R.
        Massive transfusion.
        Lab Med. 1991; 22: 94
        • Nusbacher J.
        Blood transfusion support in liver transplantation.
        Transfusion Med Rev. 1991; 5: 207
        • Otsuka S.
        • Kunieda K.
        • Hirose M.
        • et al.
        Fatal erythroderma (suspected graft-versus- host disease) after cholecystectomy.
        Transfusion. 1989; 29: 544
        • Park B.H.
        • Good R.A.
        • Gate J.
        • et al.
        Fatal graft-versus-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease.
        Transplant Proc. 1974; 6: 385
        • Parkman R.
        • Mosier D.
        • Umansky I.
        • et al.
        Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.
        N Engl J Med. 1974; 290: 359
        • Phillips T.F.
        • Soulier G.
        • Wilson R.F.
        Outcome of massive transfusion exceeding two blood volumes in trauma and emergency surgery.
        J Trauma. 1987; 27: 903
        • Piszkiewicz D.
        • Apfelzweig R.
        • Bourret L.
        • et al.
        Inactivation of HIV in antithrombin- III concentrate by pasteurization [letter].
        Transfusion. 1988; 28: 198
        • Preiksaitis J.K.
        • Brown L.
        • McKenzie M.
        Transfusion-acquired cytomegalovirus infection in neonates: A prospective study.
        Transfusion. 1988; 28: 205
        • Prince M.
        • Szer J.
        • van der Weyden M.B.
        • et al.
        Transfusion associated graft-versus- host disease after cardiac surgery: Response to antithymocyte-globulin and corticosteroid therapy.
        Aust NZ J Med. 1991; 21: 43
        • Reed R.L.
        • Ciavarella D.
        • Heimbach D.M.
        • et al.
        Prophylactic platelet administration during massive transfusion.
        Ann Surg. 1986; 203: 40
        • Reuler J.B.
        Hypothermia: Pathophysiology, clinical settings and management.
        Ann Intern Med. 1978; 89: 519
        • Roberton N.R.C.
        Top up transfusions in neonates.
        Arch Dis Child. 1987; 62: 984
        • Rosen R.C.
        • Huestis D.W.
        • Corrigan J.J.
        Acute leukemia and granulocyte transfusion: Fatal graft-versus-host reaction following transfusion of cells obtained from normal donors.
        J Pediatr. 1978; 93: 268
        • Sacher R.A.
        • Luban N.L.C.
        • Strauss R.G.
        Current practice and guidelines for the transfusion of cellular blood components in the newborn.
        Transfusion Med Rev. 1989; 3: 39
        • Sakakibara T.
        • Ida T.
        • Mannouji E.
        • et al.
        Post-transfusion graft-versus-host disease following open heart surgery.
        J Cardiovasc Surg. 1989; 30: 687
        • Sanders M.R.
        • Graeber J.E.
        Posttransfusion graft-versus-host disease in infancy.
        J Pediatr. 1990; 117: 159
        • Satiani B.
        • Fried S.J.
        • Zeeb P.
        • et al.
        Normothermic rapid volume replacement in traumatic hypovolemia.
        Arch Surg. 1987; 122: 1044
        • Sawyer P.R.
        • Harrison C.R.
        Massive transfusion in adults.
        Vox Sang. 1990; 58: 199
        • Schwab W.
        • Shayne J.P.
        • Turner J.
        Immediate trauma resuscitation with type O uncrossmatched blood: A two-year prospective experience.
        J Trauma. 1986; 26: 897
        • Seegers W.H.
        • Johnson J.F.
        • Fell C.
        An antithrombin reaction related to prothrombin activation.
        Am J Physiol. 1954; 176: 97
        • Sheehan T.
        • McLaren K.M.
        • Brettle R.
        • et al.
        Transfusion-induced graft versus host disease in pregnancy.
        Clin Lab Haematol. 1987; 9: 205
        • Siskind G.W.
        • Thomas L.
        Studies on the runting syndrome in newborn mice.
        J Exp Med. 1959; 110: 511
        • Slichter S.J.
        Transfusion and bone marrow transplantation.
        Transfusion Med Rev. 1988; 2: 1
        • Spitzer T.R.
        • Cahill R.
        • Cottier-Fox M.
        • et al.
        Transfusion-induced graft-versus-host disease in patients with malignant lymphoma.
        Cancer. 1990; 66: 2346
        • Strauss R.G.
        Neonatal anemia: Pathophysiology and treatment.
        in: Wilson S.M. Levitt J.S. Strauss R.G. Improving Transfusion Practice for Pediatric Patients. American Association of Blood Banks, Arlington, VA1991: 1
        • Strauss R.G.
        • Barnes A.
        • Blanchette V.S.
        • et al.
        Directed and limited exposure blood donations for infants and children.
        Transfusion. 1990; 30: 68
        • Strauss R.G.
        • Wieland M.R.
        • Randels M.J.
        • et al.
        Feasibility and success of a single donor blood program for pediatric elective surgery patients [abstract].
        Transfusion. 1991; 31: 50S
        • Strobel S.
        • Morgan G.
        • Simmonds A.H.
        • et al.
        Fatal graft versus host disease after platelet transfusion in a child with purine nucleoside phosphorylase deficiency.
        Eur J Pediatr. 1989; 148: 312
        • Tegtmeier G.E.
        The use of cytomegalovirus-screened blood in neonates.
        Transfusion. 1988; 28: 201
        • Thaler M.
        • Shamiss A.
        • Orgad S.
        • et al.
        The role of blood from HLA-homozyous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
        N Engl J Med. 1989; 321: 25
        • Valeri C.R.
        • Feingold H.
        • Cassidy G.
        • et al.
        Hypothermia-induced reversible platelet dysfunction.
        Ann Surg. 1987; 205: 175
        • Valerius N.H.
        • Johansen K.S.
        • Nielson O.S.
        • et al.
        Effect of in vitro x-irradiation on lymphocyte and granulocyte function.
        Scand J Haematol. 1981; 27: 9
        • Vinazzer H.
        Clinical use of antithrombin III concentrates.
        Vox Sang. 1987; 53: 193
        • Von Fliedner V.
        • Higby D.J.
        • Kim U.
        Graft-versus-host reaction following blood transfusion.
        Am J Med. 1982; 72: 951
        • Westphal R.
        • Howard P.L.
        HLA-homozygous donors and transfusion-associated graft- versus-host disease [letter].
        N Engl J Med. 1990; 322: 1006
        • Wilson R.F.
        • Dulchavsky S.A.
        • Soullier G.
        • et al.
        Problems with 20 or more blood transfusions in 24 hours.
        Am Surg. 1987; 53: 410
        • Wudel J.H.
        • Morris J.A.
        • Yates K.
        • et al.
        Massive transfusion: Outcome in blunt trauma patients.
        J Trauma. 1991; 31: 1
        • Yabuki A.
        • Yamaji K.
        • Ohki H.
        • et al.
        Characterization of a pyridoxalated hemoglobin- polyoxyethylene conjugate as a physiologic oxygen carrier.
        Transfusion. 1990; 30: 516
        • Yawn D.H.
        Properties of salvaged blood.
        in: Taswell H.F. Pineda A.A. Autologous Transfusion and Hemotherapy. Blackwell Scientific, Boston1990: 194-206
        • Yeager A.S.
        • Grumet F.C.
        • Hafleigh E.B.
        • et al.
        Prevention of transfusion-acquired cytomegalovirus infections in newborn infants.
        J Pediatr. 1981; 98: 281

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30485-2

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX